| |
 |
ARTICLES 
|
|
| Modulation of multidrug resistance: at the threshold |
| BI Sikic |
|
JCO Sep 1 1993: 1629–1635.
[PDF]
|
 |
| Postremission therapy for the younger adult patient with acute myelogenous leukemia: defining a role for transplantation |
| DD Hurd |
|
JCO Sep 1 1993: 1636–1638.
[PDF]
|
|
| The clinical cancer researcher--still an embattled species |
| E Frei, 3d and EJ Freireich |
|
JCO Sep 1 1993: 1639–1651.
[PDF]
|
|
|
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia |
| |
AF List, C Spier, J Greer, S Wolff, J Hutter, R Dorr, S Salmon, B Futscher, M Baier, and W Dalton |
| |
JCO Sep 1 1993: 1652–1660.
[Abstract]
[PDF]
|
|
|
Busulfan plus cyclophosphamide followed by autologous blood stem-cell transplantation for patients with acute myeloblastic leukemia in first complete remission: a report from a single institution |
| |
MA Sanz, J de la Rubia, GF Sanz, G Martin, J Martinez, I Jarque, A Sempere, F Gomis, L Senent, and MA Soler |
| |
JCO Sep 1 1993: 1661–1667.
[Abstract]
[PDF]
|
|
|
Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma |
| |
J Finke, J Slanina, W Lange, and G Dolken |
| |
JCO Sep 1 1993: 1668–1673.
[Abstract]
[PDF]
|
|
|
Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression |
| |
A Carbone, U Tirelli, A Gloghini, R Volpe, and M Boiocchi |
| |
JCO Sep 1 1993: 1674–1681.
[Abstract]
[PDF]
|
|
|
Clinical activity of a cytotoxic fusion protein in the treatment of cutaneous T-cell lymphoma |
| |
P Hesketh, P Caguioa, H Koh, H Dewey, A Facada, R McCaffrey, K Parker, P Nylen, and T Woodworth |
| |
JCO Sep 1 1993: 1682–1690.
[Abstract]
[PDF]
|
|
|
Novel oral combination chemotherapy in the treatment of intermediate- grade and high-grade AIDS-related non-Hodgkin's lymphoma |
| |
SC Remick, JJ McSharry, BC Wolf, CG Blanchard, AY Eastman, H Wagner, E Portuese, T Wighton, D Powell, and T Pearce |
| |
JCO Sep 1 1993: 1691–1702.
[Abstract]
[PDF]
|
|
|
Secondary neoplasms following treatment of malignant germ cell tumors |
| |
C Bokemeyer and HJ Schmoll |
| |
JCO Sep 1 1993: 1703–1709.
[Abstract]
[PDF]
|
|
|
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node- positive and estrogen receptor-negative patients: a Southwest Oncology Group study |
| |
SE Rivkin, S Green, B Metch, WR Jewell, JJ Costanzi, SJ Altman, JP Minton, RM O'Bryan, and CK Osborne |
| |
JCO Sep 1 1993: 1710–1716.
[Abstract]
[PDF]
|
|
|
S-phase fraction is a prognostic factor in stage I breast carcinoma |
| |
O Stal, M Dufmats, T Hatschek, J Carstensen, C Klintenberg, LE Rutqvist, L Skoog, S Sullivan, S Wingren, and B Nordenskjold |
| |
JCO Sep 1 1993: 1717–1722.
[Abstract]
[PDF]
|
|
|
Assessment of estrogenic recruitment before chemotherapy in advanced breast cancer: a double-blind randomized study. European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group |
| |
R Paridaens, JC Heuson, JP Julien, C Veyret, J Van Zyl, JG Klijn, R Sylvester, and F Mignolet |
| |
JCO Sep 1 1993: 1723–1728.
[Abstract]
[PDF]
|
|
|
Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation |
| |
SI Bearman, GL Anderson, M Mori, MS Hinds, HM Shulman, and GB McDonald |
| |
JCO Sep 1 1993: 1729–1736.
[Abstract]
[PDF]
|
|
|
Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma |
| |
JL Grem, E Jordan, ME Robson, RA Binder, JM Hamilton, SM Steinberg, SG Arbuck, RA Beveridge, AN Kales, and JA Miller |
| |
JCO Sep 1 1993: 1737–1745.
[Abstract]
[PDF]
|
|
|
Clinical trial of Serratia marcescens extract and radiation therapy in patients with malignant astrocytoma |
| |
KL Black, JD Ciacci, M Ammirati, MT Selch, and DP Becker |
| |
JCO Sep 1 1993: 1746–1750.
[Abstract]
[PDF]
|
|
|
Intraoperative lymphatic mapping and selective cervical lymphadenectomy for early-stage melanomas of the head and neck |
| |
DL Morton, DR Wen, LJ Foshag, R Essner, and A Cochran |
| |
JCO Sep 1 1993: 1751–1756.
[Abstract]
[PDF]
|
|
|
Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials |
| |
KM Pisters, MG Kris, RJ Gralla, MB Zaman, RT Heelan, and N Martini |
| |
JCO Sep 1 1993: 1757–1762.
[Abstract]
[PDF]
|
|
|
Prognostic significance of histopathologic response to chemotherapy in nonmetastatic Ewing's sarcoma of the extremities |
| |
P Picci, BT Rougraff, G Bacci, JR Neff, L Sangiorgi, A Cazzola, N Baldini, S Ferrari, M Mercuri, and P Ruggieri |
| |
JCO Sep 1 1993: 1763–1769.
[Abstract]
[PDF]
|
|
|
Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma |
| |
A Garaventa, B De Bernardi, C Pianca, A Donfrancesco, L Cordero di Montezemolo, MT Di Tullio, S Bagnulo, A Mancini, M Carli, and A Pession |
| |
JCO Sep 1 1993: 1770–1779.
[Abstract]
[PDF]
|
|
|
Comparative pharmacokinetic studies of three asparaginase preparations |
| |
BL Asselin, JC Whitin, DJ Coppola, IP Rupp, SE Sallan, and HJ Cohen |
| |
JCO Sep 1 1993: 1780–1786.
[Abstract]
[PDF]
|
|
|
Phase I clinical trial of carboplatin and 41.8 degrees C whole-body hyperthermia in cancer patients |
| |
HI Robins, JD Cohen, CL Schmitt, KD Tutsch, C Feierabend, RZ Arzoomanian, D Alberti, F d'Oleire, W Longo, and C Heiss |
| |
JCO Sep 1 1993: 1787–1794.
[Abstract]
[PDF]
|
|
|
Phase I study of high-dose piroxantrone with granulocyte colony- stimulating factor |
| |
DM Savarese, AM Denicoff, SL Berg, M Hillig, SP Baker, JA O'Shaughnessy, C Chow, GA Otterson, FM Balis, and DG Poplack |
| |
JCO Sep 1 1993: 1795–1803.
[Abstract]
[PDF]
|
|
|
Prognostic significance of Ki-67 immunostaining in nonmetastatic renal cell carcinoma |
| |
WT de Riese, WN Crabtree, EP Allhoff, M Werner, S Liedke, G Lenis, J Atzpodien, and H Kirchner |
| |
JCO Sep 1 1993: 1804–1808.
[Abstract]
[PDF]
|
|
|
Subcutaneous interleukin-2 plus interferon alfa-2a in metastatic renal cancer: an outpatient multicenter trial |
| |
NJ Vogelzang, A Lipton, and RA Figlin |
| |
JCO Sep 1 1993: 1809–1816.
[Abstract]
[PDF]
|
|
|
Does interleukin-2 have a role in the management of acute leukemia? |
| |
R Foa |
| |
JCO Sep 1 1993: 1817–1825.
[Abstract]
[PDF]
|
|
|
Intravenous mercaptopurine: life begins at 40 |
| |
D Pinkel |
| |
JCO Sep 1 1993: 1826–1831.
[Abstract]
[PDF]
|
|
| Rethinking management of localized neuroblastoma |
| BH Kushner, MP LaQuaglia, and NK Cheung |
|
JCO Sep 1 1993: 1832a–1834.
|
|
| High-dose melphalan is not associated with extramedullary relapses in high-risk multiple myeloma |
| P Moreau, R Bataille, B Mahe, N Milpied, and JL Harousseau |
|
JCO Sep 1 1993: 1832b.
|
|
| More on follicular lymphomas |
| JR Anderson, JO Armitage, and DD Weisenberger |
|
JCO Sep 1 1993: 1834–1836.
[PDF]
|
|
| Adoptively transferred anti-CD3-activated T cells for human tumor immunotherapy |
| JE Gold |
|
JCO Sep 1 1993: 1836–1837.
[PDF]
|
|
| The center responds to the fringe |
| SM Grunberg |
|
JCO Sep 1 1993: 1837–1838.
[PDF]
|
|
| Palindromic baldness: cytotoxic drugs correct alopecia |
| AS Spiers and JM DeFelice |
|
JCO Sep 1 1993: 1838a.
[PDF]
|
|
| Physician advocacy deficit |
| EP Schonfeld |
|
JCO Sep 1 1993: 1838b–1839.
[PDF]
|
|
